GO
Loading...

Drug Retail

More

  • FRANKFURT, March 27- Nine months after Apple and IBM began working together on building mobile apps for businesses, some of the first fruits are about to appear at UK pharmacy chain Boots, which has begun equipping store employees with iPads to serve shoppers in the aisles. Companies across dozens of different industries are now eyeing how these mobile business...

  • One iconic singer has high hopes for a pot brand Friday, 27 Mar 2015 | 8:43 AM ET
    Willie Nelson performs at the MusiCares 2015 Person Of The Year gala honoring Bob Dylan in Los Angeles, Feb. 6, 2015.

    Music icon Willie Nelson is going into the weed business, according to a pot activist.

  • Feb 17- CVS Health Corp, the second-largest U.S. pharmacy chain operator, has warned that a new class of drugs being developed to lower "bad" cholesterol could cost the U.S. healthcare system as much as $150 billion per year. The new class of cholesterol drugs called PCSK9 inhibitors could be priced in the range of $7,000- $12,000 per year, CVS said.

  • Feb 11- Drugstore operator Rite Aid Corp agreed to buy pharmacy benefit manager EnvisionRx for about $2 billion, looking to cut drug procurement costs as reimbursement rates fall. Rite Aid's deal comes nearly a decade after larger rival CVS Health Corp bought Caremark Rx for $21 billion, the only other example of a drug chain buying a benefits manager.

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, entering the business of administering health plan benefits. The deal will help Rite Aid compete better with CVS Health Corp, which bought Caremark Rx for $21 billion in 2006.. The acquisition of EnvisionRx will also give Rite Aid access to more...

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, to enter the business of administering drug benefits for employers. The third-largest U.S. drug-store chain said it would pay about $1.8 billion in cash and $200 million in stock. Rite Aid's shares rose 3 percent to $7.88 in premarket trading.

  • Feb 10- CVS Health Corp reported a better-than-expected quarterly net revenue, boosted by growth in its Medicaid business and strength in specialty drug sales. CVS became the first national drugstore chain in the United States to take cigarettes off its shelves from Oct. 1. CVS Health has focused on developing its specialty pharmacy business, which sells drugs...

  • Feb 10- CVS Health Corp, the No. 2 U.S. drugstore operator, reported a better-than-expected quarterly net revenue, helped by a jump in pharmacy same-store sales and strength in its specialty pharmacy business. CVS Health has focused on developing its specialty pharmacy business, which sells drugs to treat complex diseases such as multiple sclerosis, rheumatoid...

  • Orexigen CEO: Excited about obesity drug progress   Tuesday, 13 Jan 2015 | 2:22 PM ET
    Orexigen CEO: Excited about obesity drug progress

    Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.

  • Biogen Idec beefs up pain pipeline   Monday, 12 Jan 2015 | 3:16 PM ET
    Biogen Idec beefs up pain pipeline

    Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.

  • SHANGHAI, Jan 9- China will allow online sales of prescription drugs as early as this month, a policy that will open up an over 1 trillion yuan market to online pharmacy operators like Alibaba Group Holding Ltd and Wal-Mart Stores Inc.. The policy would help reform a fragmented and opaque market controlled by state-run distributors and hospitals, brought into...

  • Walgreens December same-store sales beat estimates Tuesday, 6 Jan 2015 | 11:35 AM ET

    Jan 6- Walgreen Co, the largest U.S. pharmacy chain, reported a better-than-expected jump in December comparable store sales, helped by the month containing one more Wednesday and one fewer Sunday than a year ago and higher sales of flu medicine. Walgreen, which gets more than 60 percent of its revenue from prescription drug sales, also sells non-prescription...

  • America going to pot   Friday, 2 Jan 2015 | 10:48 AM ET
    America's going to pot

    CNBC's Jane Wells shares her top three predictions for the pot industry this year, including changing bank regulations and the beginning of voters' remorse where it's legal.

  • Walgreen profit rises 16% on record prescriptions Tuesday, 23 Dec 2014 | 9:23 AM ET
    A Walgreens store is shown in Homestead, Fla.

    U.S. drugstore chain operator Walgreen reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled.

  • Dec 23- U.S. drugstore chain operator Walgreen Co reported a better-than-expected quarterly profit, helped by a record number of prescriptions filled, sending its shares up 3.6 percent. The combined cost savings for Walgreen and Alliance Boots in the quarter were about $140 million. Net income attributable to Walgreen rose 16 percent to $809 million, or 85...

  • Walgreen profit rises 16 pct on record prescriptions Tuesday, 23 Dec 2014 | 7:42 AM ET

    Dec 23- U.S. drugstore chain operator Walgreen Co reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled. Net income attributable to the company rose to $809 million, or 85 cents per share, in the first quarter ended Nov. 30, from $695 million, or 72 cents per share, a year earlier. Walgreen's shares were up 2 percent at $76 in...

  • Lottery ticket sector of 2015   Monday, 22 Dec 2014 | 12:46 PM ET
    Lottery ticket sector of 2015

    Mark Fisher, MBF Clearing Corp. chairman, shares his favorite stock in the biotech space.

  • Cramer's view of AbbVie-Express Scripts deal   Monday, 22 Dec 2014 | 8:52 AM ET
    Cramer's view of AbbVie-Express Scripts deal

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.

  • Hepatitis C virus

    Express Scripts Medical Chief Steve Miller, provides insight to his company's deal with AbbVie. The two companies have come to a deal which gives Express Scripts a significant discount on the hepatitis C drug.

  • Express Scripts gets deal for AbbVie's hepatitis C drug

    CNBC's Meg Tirrell provides insight to a newly approved hepatitis C drug from AbbVie, which Express Scripts made an exclusive deal for a significant discount on the drug.